Trial Profile
A Double-blind, Randomized, Placebo-controlled Study of the Safety and Tolerability of Increasing Doses of XC8 After Single and Repeated Oral Administration in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Jan 2020
Price :
$35
*
At a glance
- Drugs Histamine glutarimide (Primary)
- Indications Asthma
- Focus Adverse reactions
- Sponsors Pharmenterprises
- 27 Feb 2018 New trial record